Particle.news

Download on the App Store

Cancer Screenings Cut U.S. Deaths but Lung Test Participation Falters

New mortality figures from U.S. screening programs drive Spain’s move to scale its early lung cancer pilot by September.

La realización de análisis médicos en tiempo y forma es crucial para detectar a tiempo un caso y actuar cuanto antes
Las mujeres deben hacerse mamografías periódicas

Overview

  • The U.S. Preventive Services Task Force recommends routine screening for lung, breast, colorectal and cervical cancers using specific age and risk–based tests.
  • Models show these screenings reduce cancer mortality by 13% for lung tumors, up to 30% for breast cancers, 79–85% for colorectal cancers and 80–87% for cervical cancers.
  • Health insurers in the U.S. are required to cover these Task Force–endorsed screenings without cost-sharing for eligible individuals.
  • Despite coverage mandates, only 17% of eligible adults undergo annual low-dose CT scans for lung cancer compared with 65% who complete breast and colorectal screenings.
  • Spain’s Cassandra pilot detected 3.2% of lung cancers at an early stage and plans to expand its program nationwide by September.